Mark joined NICE in 2022 as interim director, medical technology and digital evaluation. In 2024, Mark was appointed as director of healthtech following an interim period in the role. This includes diagnostics, digital and medtech that can be implantable or assistive. Mark has 30 years’ experience in the medtech arena. He initially trained as a clinical physiologist and worked for 10 years within tertiary cardiac care in the NHS, with a specialist interest in complex cardiac devices.

Mark moved into industry in 2001, holding various clinical and commercial roles. In parallel, he has held roles, including committee member on NICE’s technology appraisal programme. Mark is a past member of the external advisory board, University of Leeds EPSRC Centre for Innovative Manufacturing of Medical Devices and undertook a secondment within the UK Government, Office for Life Science, Department of Business, as medtech policy advisor. From 2014, Mark was the director of health economics and commissioning for UK and Ireland at Medtronic.